A PYMNTS Company

Germany: Merck makes US$5.9B counterbid for Versum

By  |  February 28, 2019

German drugs and lab supplies maker Merck offered US$5.9 billion, including debt, for Versum Materials, in a cash deal that tops an offer from US rival Entegris, reported the Financial Times.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The unexpected counter bid for Versum, which makes critical components used in semiconductors, would bolster Merck’s performance materials unit as chipmakers and their suppliers seek to capitalize on the wave of devices that will soon connect to the internet.

    Merck announced it had offered to pay US$48 a share in cash for Versum, roughly 52% above Versum’s share price before its all-stock deal with Entegris was announced and 16% higher than its closing level on Tuesday. The US$5.9 billion deal value includes the assumption of Versum’s outstanding debt.

    Full Content: Financial Times

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.